| Dr Reddys Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500124 |
NSE Symbol : DRREDDY |
P/E(TTM) : 19.34 |
|
ISIN Demat : INE089A01031 |
Div & Yield% : 0.64 |
EPS(TTM) : 64.68 |
|
Book Value(₹) : 377.56 |
Market Cap(₹Cr) : 104,420.60 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 4,602.90 | 7,788.70 | 5,546.30 | 4,997.80 | 6,678.80 | 5,823.90 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,602.90 | 7,788.70 | 5,546.30 | 4,997.80 | 6,678.80 | 5,823.90 |
| Other Operating Income | 15.70 | 20.80 | 16.60 | 17.20 | 17.50 | 17.30 |
| Other Income | 364.20 | 398.30 | 414.40 | 235.40 | 207.60 | 217.80 |
| Total Income | 4,982.80 | 8,207.80 | 5,977.30 | 5,250.40 | 6,903.90 | 6,059.00 |
| Total Expenditure | 4,138.30 | 3,972.50 | 4,119.90 | 3,822.60 | 3,974.70 | 3,888.20 |
| PBIDT | 844.50 | 4,235.30 | 1,857.40 | 1,427.80 | 2,929.20 | 2,170.80 |
| Interest | 33.40 | 19.20 | 31.10 | 43.30 | 28.40 | 7.10 |
| PBDT | 811.10 | 4,216.10 | 1,826.30 | 1,384.50 | 2,900.80 | 2,163.70 |
| Depreciation | 294.80 | 279.80 | 264.50 | 265.10 | 260.00 | 249.80 |
| Tax | 77.70 | 941.70 | 364.30 | 256.30 | 703.30 | 466.60 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 51.30 | 33.40 | -3.20 | 13.70 | 55.40 | 30.10 |
| Reported Profit After Tax | 387.30 | 2,961.20 | 1,200.70 | 849.40 | 1,882.10 | 1,417.20 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 387.30 | 2,961.20 | 1,200.70 | 849.40 | 1,882.10 | 1,417.20 |
| EPS (Unit Curr.) | 4.65 | 35.59 | 14.41 | 10.20 | 113.00 | 85.10 |
| EPS (Adj) (Unit Curr.) | 4.65 | 35.59 | 14.41 | 10.20 | 22.60 | 17.02 |
| Calculated EPS (Unit Curr.) | 4.64 | 35.46 | 14.40 | 10.18 | 112.84 | 84.96 |
| Calculated EPS (Adj) (Unit Curr.) | 4.64 | 35.46 | 14.40 | 10.18 | 22.57 | 16.99 |
| Calculated EPS (Ann.) (Unit Curr.) | 18.55 | 141.85 | 57.59 | 40.74 | 451.34 | 339.86 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 18.55 | 141.85 | 57.59 | 40.74 | 90.27 | 67.97 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 83.50 | 83.50 | 83.40 | 83.40 | 83.40 | 83.40 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 18.35 | 54.38 | 33.49 | 28.57 | 43.86 | 37.27 |
| PBDTM(%) | 17.62 | 54.13 | 32.93 | 27.70 | 43.43 | 37.15 |
| PATM(%) | 8.41 | 38.02 | 21.65 | 17.00 | 28.18 | 24.33 |